Title: Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.
Journal: Bioorganic & medicinal chemistry letters 20111001
1133115-97-5
1133115-42-0
1823489-86-6
127958-02-5
887408-28-8
1280786-64-2 | 3-Bromo-2-(N-t-butylamino)-5-trifluoromethylpyridine | AA000XP6 | MFCD18783203
128455-62-9 | 5-Chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carbaldehyde | AA000Y10 | MFCD00068130
128790-14-7 | 2-(Chloromethyl)-5-(trifluoromethyl)pyridine | AA000YBV | MFCD10697590
129075-49-6 | 5-Methoxy-3,4-dihydroisoquinolin-1(2h)-one | AA000YQH | MFCD07196047
129254-76-8 | Benzene, 1-(3-bromopropyl)-3-(trifluoromethyl)- | AA000YY7 | MFCD09744414
1316-98-9 | Ferrocene, (1,1-dimethylethyl)- | AA000ZE9 | MFCD00058729
131782-50-8 | 3,5-Difluoro-2-methoxybenzaldehyde | AA000ZNB | MFCD06246883
132-53-6 | 2-Nitroso-1-naphthol | AA000ZYT | MFCD00003932
132203-70-4 | Cilnidipine | AA0010AZ | MFCD00865853
132465-10-2 | 2-Propenoic acid, 2-cyano-3-(3,4-dihydroxyphenyl)-, 2-(2-thienyl)ethyl ester, (E)- (9CI) | AA0010M9 | MFCD00894731